TrialSignal
Clinical trial intelligence report
COmorbidities and EDucation in SpondyloArthritis Study (COMEDSPA) Evaluation of Standardized Follow-up in Axial Spondyloarthritis
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT02374749-Jul 28, 2026
NCT ID
NCT02374749
Status
COMPLETED
Phase
Completed
Sponsor
Assistance Publique - Hôpitaux de Paris
Executive brief
Investment-Ready Snapshot
The COMEDSPA study, sponsored by Assistance Publique
Hôpitaux de Paris, evaluated the impact of a nurse-led program on self-assessment and management of axial spondyloarthritis (SpA) and the systematic evaluation of comorbidities. With an enrollment of 503 patients across 21 centers in France, the study aimed to address the gap between clinical practice and existing recommendations for managing comorbidities in SpA patients. The results may provide insights into enhancing patient outcomes and adherence to treatment protocols, which could be leveraged for market positioning in rheumatology care. The findings could also inform potential collaborations with healthcare providers and payers focused on improving patient management strategies in chronic inflammatory diseases.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02374749
Indication
Axial Spondyloarthritis
Modality
behavioral intervention
Target
Axial Spondyloarthritis management through nurse-led self-assessment and comorbidity evaluation.
Intervention
self-assessment/self-management, Comorbidities (detection/prevention)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.